E2F8 and lung carcinoma: In this study, siRNA-mediated knockdown of E2F8 in lung cancer cells significantly suppressed cell proliferation while overexpression of E2F8 recovered metformin-induced inhibition of cell proliferation, suggesting that E2F8 may be a molecular target for inhibition of proliferation by metformin in lung cancer cells.